VITAMIN C INFUSION

VITAMIN C INFUSION

The NIH study confirms in vitro, the hypotheses described by Riordan et al in “Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent”:
· Tumor cells are more susceptible to the effects of high-dose, ascorbate-induced peroxidation products because of a relative catalase deficiency.
· Concentrations of ascorbate high enough to kill tumor cells can be achieved in humans.
· Vitamin C was an effective anti-tumor therapy as long as high enough concentrations of it could be achieved inside the tumor(s).
· Since cancer patients are often depleted of vitamin C, replenishment may improve immune system function and enhance patient health and well-being.
· High dose IVC is a non-toxic chemotherapeutic agent that can be given in conjunction with conventional cancer treatments and when is administered in high doses by intravenous (I.V.) infusions, can kill cancer cells.

https://lpi.oregonstate.edu/es/mic/vitaminas/vitamina-C

Make an appointment

Please complete all fields to make an appointment request . All fields are required *